Test Price
3,000 AED✅ Home Collection Available
Comprehensive Ear Nose Throat Panel Genetic Test in UAE | DNA Labs UAE
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% analytical sensitivity via ISO-compliant NGS processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection – available daily from 8 AM to 11 PM.
- Clinical Guidance: Post-test telephonic consultation with a consultant medical geneticist for result interpretation.
- Insurance: Direct coverage verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This advanced Next‑Generation Sequencing (NGS) analysis decodes 225+ genes associated with hereditary hearing loss, congenital ear malformations, and syndromic or non‑syndromic ENT disorders, delivering clinically actionable results within 3–4 weeks. The panel covers genes implicated in Usher syndrome, CHARGE syndrome, Pendred syndrome, and non‑syndromic hearing loss loci such as GJB2, SLC26A4, MYO15A, and OTOF.
| Feature | Our NGS Panel | Single‑Gene Sequencing |
|---|---|---|
| Gene Coverage | 225+ genes simultaneously | One gene per test |
| Methodology | NGS with >99.9% analytical sensitivity | Sanger sequencing, limited scope |
| Turnaround Time | 3–4 weeks | 8–12 weeks cumulative |
| Clinical Utility | Comprehensive etiological diagnosis & family planning | Targeted; often requires sequential tests |
Physician Insight & Safety Protocols
“Hereditary ENT disorders often present with overlapping clinical features that make diagnosis challenging. This NGS panel offers a comprehensive genetic survey that can identify the underlying molecular cause in a single workflow, enabling targeted surveillance and family counselling. However, results must always be interpreted in the context of a complete audiological and otolaryngological evaluation.” – Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Notice
Genetic test results are supportive and must be correlated with clinical history, physical examination, and audiometric data. Do not discontinue or alter any prescribed treatment without direct consultation with your managing physician.
Exclusion Criteria & Urgent Indications
- Exclusion criteria: Patients with active bloodstream infections or allogeneic blood transfusion within the past 14 days may require delayed collection. Minors must be accompanied by a legal guardian as mandated by Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Red Flags – seek emergency care immediately if you experience: Sudden total hearing loss, acute facial nerve paralysis, severe vertigo with nausea or vomiting, or bloody or clear fluid discharge from the ear.
Patient FAQ & Clinical Guidance
1. What is the turnaround time and what will the results tell my ENT doctor?
The NGS panel is completed within 3 to 4 weeks and produces a digital report detailing pathogenic and likely pathogenic variants linked to hereditary hearing loss or ENT malformations. Your ENT specialist uses these findings to confirm a genetic aetiology, plan further audiological assessments, discuss recurrence risks with family members, and guide multi‑disciplinary management when syndromic associations such as Usher or CHARGE syndrome are identified.
2. How is the sample collected and is it painful?
A certified phlebotomist visits your home for a standard venipuncture blood draw, or you may provide a single drop of blood on an FTA card – both methods are quick and minimally uncomfortable. All samples are transported under ISO‑certified cold‑chain conditions to preserve DNA integrity. The process fully complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL), ensuring your genetic information remains confidential.
3. Is the test covered by insurance and is pre-test counselling available?
Our team verifies coverage directly with your insurer via WhatsApp (+971 54 548 8731) before scheduling. A mandatory genetic counselling session is arranged to document a detailed family pedigree and confirm medical appropriateness. Per Federal Decree-Law No. 4 of 2016 on Medical Liability, all genetic testing requires informed consent; we provide comprehensive pre-test counselling and telephonic post-test guidance. For minors, parental or guardian consent is strictly obtained in accordance with UAE regulations.
UAE Regulatory & Data Privacy Adherence
- Licensed by DHA under facility license number 1143.
- All genetic testing complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Patient consent and safety protocols follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Quality management system certified to ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139).
- Methodology validated against accredited reference datasets; NGS with optional LC‑MS/MS biochemical confirmation as indicated.
Clinical & Logistical Metadata
| Test Name | Comprehensive Ear Nose Throat Panel Genetic Test (NGS) |
| Price (AED) | 3,000 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA) or FTA card dried blood spot; DNA extracted from viable lymphocytes |
| Methodology Used | Next‑Generation Sequencing (NGS) – targeted panel, Illumina platform, >99.9% analytical sensitivity |
| ICD-10-CM Code | H90.5, H90.3, H91.90, Z14.8 |
| LOINC Code | 81247-0 – Genetic analysis NGS panel – Blood or Tissue |
| DHA Facility License & Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians